5 Letter from our Chairman Dear Stakeholder, A consistent track record of over two decades has enabled Sai Life Sciences earn the trust of its stakeholders for its commitment and capability to deliver value. We take a holistic approach to ensure that whatever we do impacts each of our stakeholders in a positive way. Though the year 2020 was challenging and uncertain, our collective ability of being agile kept the momentum going. We viewed the pandemic as an opportunity to lead in a more positive and impactful way. The need to respond with agility, yet thoughtfully, was fully supported by our leaders and our people, helping us stay on track with the efforts to meet our sustainability goals. In 2019, we said that the momentum of sustainability is making Sai Life Sciences aspire to be the best for the world. As the world, including us, was dealing with the challenges of COVID-19, a break in the pharmaceutical supply chain serviced by CDMOs was imminent. However, our commitment and well-planned operations kept the supply chain productive and supportive of customers’ goals. Sai Life Sciences is pursuing a sustainable growth model drawing upon multidisciplinary talent in science and technology and a human-centered ethos—focused on customer delight, empowered people, and a team-based work environment. Our sustainability journey is strongly rooted in our core values of Integrity, Transparency, Ownership, Reliability, Respect, Collaboration, which serve as cultural cornerstones, giving us the strength to thrive. As we continue to operate in a world where COVID-19 related challenges are still not behind us, we are taking a call for an unrelenting response. Sustainability is at a turning point -- which means more focus on serving our customers who meet global unmet medical needs, taking concrete steps to address climate change, and keeping our operations sustainable and safe, while being connected to the community. Sincerely, K Ranga Raju Chairman
RkJQdWJsaXNoZXIy MTIwMDc4NQ==